Replies to post #88581 on Biotech Values

[genisi]

I would think that GS9350 would need to show superiority to ritonavir in some respect for it to supplant ritonavir as the PI-boosting agent of choice in HIV.

You think that if it is at least as good and safe boosting agent as ritonavir, it won't be enough for the quad-pill?